Drug Repurposing News and Research

RSS

Repurposed quinacrine can reduce tumor burden in mice bearing HNSCC xenograft tumors

The authors have developed the Accelera TED platform to repurpose drugs for HNSCC treatment; using in vitro assays and in vivo models.

11 Oct 2019

Using zebrafish to discover and identify new drugs to treat spinal cord lesions

A research team led by Leonor Saúde, Principal Investigator at Instituto de Medicina Molecular, in partnership with the company Technophage, SA, has designed a simple and efficient platform that uses zebrafish to discover and identify new drugs to treat spinal cord lesions.

22 Jul 2019

Starving the fungus could help fight drug-resistant fungal infections

How do you fight a fungal infection that is becoming increasingly resistant to medicine? By starving it, found a team of University at Buffalo and Temple University researchers.

26 May 2019

New ReFRAME drug repurposing collection offers hope for treating major diseases

Each year, millions of people worldwide suffer from potentially fatal infectious diseases that often leave survivors facing a lifetime of related health problems. But what if drugs against such diseases already existed but nobody knew it?

4 Oct 2018

American Pain Society encouraged by progress toward increased funding for pain research

It's been more than two years since the National Institutes of Health released its National Pain Strategy, a comprehensive population health-level strategy for pain, and a year since announcing its Federal Pain Strategy, a long-term strategic plan for pain research.

6 Sep 2018

Study finds role of autoimmunity in development of COPD

Autoimmunity plays a role in the development of chronic obstructive pulmonary disease (COPD), according to a study led by Georgia State University and Vanderbilt University Medical Center that analyzed human genome information stored in Vanderbilt's DNA biobank.

16 Aug 2018

Non-aspirin NSAID use linked to shorter survival in patients with metastatic renal cell carcinoma

Ibuprofen, aspirin, and other non-steroidal anti-inflammatory medications are among the most commonly utilized medications in the United States. Primarily for treating pain, inflammation, and preventing cardiovascular disease, NSAIDs' promising anti-cancer properties have been highlighted by a growing body of data in recent years.

2 May 2018

Insilico’s CEO to deliver presentation on “Artificial Intelligence for Aging Research”

Insilico Medicine, a Baltimore-based company specializing in the application of next-generation artificial intelligence for drug discovery, biomarker development and aging research, announces the presentation of its CEO, Alex Zhavoronkov, at the Pioneers 18 Conference, May 25, 2018, Vienna, Austria.

28 Apr 2018

Insilico to present recent advances in AI for aging biomarkers and age management research

Insilico Medicine, a Baltimore-based next-generation artificial intelligence company specializing in the application of deep learning for drug discovery, biomarker development and aging research, is pleased to announce the presentation of its Director of Drug Discovery, Dr. Ivan Ozerov, at the 24th Clinical Applications for Age Management Medicine Conference, April 27, 2018, organized by Age Management Medicine Group.

6 Apr 2018

First drug-candidate compounds discovered using AI licensed for development

Insilico Medicine, Inc., a Baltimore-based next-generation artificial intelligence company specializing in the application of deep learning for drug discovery, announces that Juvenescence.AI, its joint venture with Juvenescence Limited, has licensed its first compound family for clinical development.

7 Feb 2018

Insilico Medicine develops new deep-learning based hematological human aging clock

Today, Insilico Medicine, Inc., a Baltimore-based company specializing in the application of artificial intelligence for drug discovery, biomarker development and aging research, announced a publication of a research paper titled "Population-specific biomarkers of human aging: a big data study using South Korean, Canadian and Eastern-European patient populations" in The Journal of Gerontology.

11 Jan 2018

Deep-learning technology reveals anti-aging plant extracts

Life Extension, in collaboration with Insilico Medicine, have employed artificial intelligence to develop a novel dietary supplement of plant extracts that can activate the body's own anti-aging path ways.

31 Oct 2017

FDA approved drug found to have anti-cancer activity against previously unknown targets

Developing new drugs to treat cancer can be a painstaking process taking over a decade from start to Food and Drug Administration approval. Scientists are trying to develop innovative strategies to identify and test new drugs quicker and more efficiently.

10 Oct 2017

New crowdfunding campaign aims to develop, test novel photographic biomarkers of aging in mice

The Biogerontology Research Foundation announces the launch of a crowdfunding campaign, MouseAge, to develop and test photographic biomarkers of ageing in mice in collaboration with scientists from Harvard University, University of Oxford, Youth Laboratories and Insilico Medicine.

31 Aug 2017

Drug Repurposing News and Research

Repurposed quinacrine can reduce tumor burden in mice bearing HNSCC xenograft tumors

Using zebrafish to discover and identify new drugs to treat spinal cord lesions

Starving the fungus could help fight drug-resistant fungal infections

New ReFRAME drug repurposing collection offers hope for treating major diseases

American Pain Society encouraged by progress toward increased funding for pain research

Study finds role of autoimmunity in development of COPD

Non-aspirin NSAID use linked to shorter survival in patients with metastatic renal cell carcinoma

Insilico’s CEO to deliver presentation on “Artificial Intelligence for Aging Research”

Insilico to present recent advances in AI for aging biomarkers and age management research

First drug-candidate compounds discovered using AI licensed for development

Insilico Medicine develops new deep-learning based hematological human aging clock

Deep-learning technology reveals anti-aging plant extracts

FDA approved drug found to have anti-cancer activity against previously unknown targets

New crowdfunding campaign aims to develop, test novel photographic biomarkers of aging in mice

New partnership uses artificial intelligence methods to develop solutions for preventing early aging

Juvenescence AI to develop first compounds generated by Insilico's deep-learned drug discovery engines

Mayo Clinic and nference launch startup to develop drugs for rare diseases

AI and deep learning can help visualize human bias in complex systems

New study looks at how old drugs can be repurposed to treat infectious diseases

ActuRx and Insillico Medicine collaborate to prevent, treat age-related illnesses

Drug Discovery - Second Edition eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News